A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
Clinical trial NCT05996471 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05996471
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2026-05-27
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.